The platform will provide an end-to-end solution for biotechnology, pharma companies and other life sciences providers
eClinical Solutions, provider of end-to-end data management services and technologies announced the release of their data Intelligence Hub – elluminate. This fit for purpose platform provides an end-to-end solution for biotechnology, pharmaceutical companies and other life sciences providers looking to leverage the power of the data they are already collecting without going through a time and cost intensive implementation effort.
elluminate is a cloud-based data intelligence hub with an ability to integrate diverse datasets from different clinical systems and data sources and combines them seamlessly to help users access powerful analytics. The platform has been designed to open up an unlimited possibility for data analysis across a broad cross section of stakeholders. Companies can implement the entire platform or select capabilities below based on the needs of their organisation.
- Clinical data analytics: Facilitate data exploration to identify trends and outliers while providing traditional line listings, descriptive statistics and visual patient profiles.
- Clinical trial operations analytics: Monitoring for deeper insights into the operational health of clinical trials, delivering access to trial performance across multiple data streams in one integrated view.
- Risk-based monitoring: Utilise central monitoring practices and implement risk-based monitoring based on TransCelerate BioPharma and other strategies that enable insights into the risk aspects of clinical trial data quality, monitoring and site performance.
Elluminate was launched in 2011 as a clinical data repository and subsequent collaborations with customers and service organisations coupled with significant investment in R&D has resulted in this next generation platform.
elluminate enables clinical teams to achieve deeper insights in real-time allowing organisations to achieve their business goals.
EP News Bureau